Gray, G., Metch, B., Churchyard, G., Mlisana, K., Nchabeleng, M., Allen, M., . . . Bekker, L. (2013). Does participation in an HIV vaccine efficacy trial affect risk behaviour in South Africa? Vaccine, 31(16), 2089. https://doi.org/10.1016/j.vaccine.2013.01.031
Chicago Style (17th ed.) CitationGray, G.E, B. Metch, G. Churchyard, K. Mlisana, M. Nchabeleng, M. Allen, Z. Moodie, J. Kublin, and L.-G Bekker. "Does Participation in an HIV Vaccine Efficacy Trial Affect Risk Behaviour in South Africa?" Vaccine 31, no. 16 (2013): 2089. https://doi.org/10.1016/j.vaccine.2013.01.031.
MLA (9th ed.) CitationGray, G.E, et al. "Does Participation in an HIV Vaccine Efficacy Trial Affect Risk Behaviour in South Africa?" Vaccine, vol. 31, no. 16, 2013, p. 2089, https://doi.org/10.1016/j.vaccine.2013.01.031.